The expression of Met/hepatocyte growth factor receptor gene in giant cell tumors of bone and other benign musculoskeletal tumors

Journal of Cellular Physiology

Volumn 184, Issue 2, 2000, Pages 191-196

  Ferracini, Riccardo ^a   Scotlandi, Katia ^b   Cagliero, Elga ^a   Acquarone, Francesca ^a   Olivero, Martina ^a   Wunder, Jay ^c   Baldini, Nicola ^b  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c Hôpital Mount Sinai   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR RECEPTOR;

ADULT; ARTICLE; BENIGN TUMOR; BONE TUMOR; CHONDROBLASTOMA; CLINICAL ARTICLE; FEMALE; FIBROMA; GENE OVEREXPRESSION; GIANT CELL TUMOR; HUMAN; HUMAN TISSUE; MALE; OSTEOBLASTOMA; OSTEOCLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; TUMOR BIOPSY;

ADULT; BONE NEOPLASMS; FEMALE; GENE EXPRESSION; GIANT CELL TUMOR OF BONE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCULOSKELETAL DISEASES; PROTO-ONCOGENE PROTEINS C-MET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033947527     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4652(200008)184:2<191::AID-JCP6>3.0.CO;2-B     Document Type: Article

References (45)

1. Bardelli A, Pugliese L, Comoglio PM. 1997. "Invasive-growth" signaling by the Met/HGF receptor. The hereditary renal carcinoma connection. Biochim Biophys Acta - Rev Cancer 1333:M41-M51.
2. Beilmann M, Odenthal M, Jung W, Vande Woude GF, Dienes HP, Schirmacher P. 1997. Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood 90(11):4450-4458.
3. Beviglia L, Matsumoto K, Lin CS, Ziober BL, Kramer LH. 1997. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int J Cancer 74:301-309.
4. Campanacci M, Baldini N, Boriani S, Sudanese A. 1987. Giant-cell tumor of bone. J Bone Joint Surg [Am] 69(1):106-114.
5. Comoglio PM. 1996. The Hepatocyte Growth Factor Receptor (MET): an unconventional transducer of mitogenic and morphogenic signals. Growth Factors and Cytokines in Health and Disease 1B:465-490.
6. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, Vande Woude GF. 1984. Molecular-cloning of a new transforming gene from a chemically transformed human cell-line. Nature 311: 29-33.
7. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM. 1991. Expression of the Met/ HGF receptor in normal and neoplastic human tissues. Oncogene 6:1997-2003.
8. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, et al. 1995. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1(2): 147-154.
9. Enneking WF. 1983. Staging of musculoskeletal tumors. In: Musculoskeletal tumor surgery. Vol I. New York: Churchill-Livingston. p. 69-88.
10. Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini PL, Cremona O, Campanacci M, Comoglio PM. 1995. The Met/HGF receptor is over-expressed in human osteosarcomas and activated by either a paracrine or an autocrine circuit. Oncogene 10:739-749.
11. Ferracini R, Olivero M, Di Renzo MF, Martano M, De Giovanni C, Nanni P, Basso G, Scotlandi K, Lollini PL, Comoglio PM. 1996. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 12(8):1697-1705.
12. Fukuda T, Ichimura E, Shinozaki T, Sano T, Kashiwabara K, Oyama T, Nakojima T, Nakamura T. 1998. Coexpression of HGF and c-Met/ HGF receptor in human bone and soft tissue tumors. Pathol Int 48:757-762.
13. Gambarotta G, Pistoi S, Giordano S, Comoglio PM, Santoro C. 1994. Structure and inducible regulation of the human MET promoter. J Biol Chem 269:12852-12857.
14. Grano M, Galimi F, Zambonin G, Colucci S, Cottone E, Zallone AZ, Comoglio PM. 1996. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci USA 93(15):7644-7648.
15. Halaban R, Rubin J, Funasaka Y, Cobb C, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W, Cook C, Moellmann G. 1992. Met and HGF/SF signal transduction in normal melanocytes and melanoma cells. Oncogene 7:2195-2206.
16. Huvos AG. 1981. "Benign" metastasis in giant cell tumor of bone. Hum Pathol 12(12):1151.
17. Liu Y. 1998. The human hepatocyte growth factor gene: complete structural organization and promoter characterization. Gene 215: 159-169.
18. Jeffers M, Fiscella M, Webb CP, Anver M, Koochekpour S, Vande Woude GF. 1998. The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci 95:14417-14422.
19. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
20. Maggiora P, Gambarotta G, Olivero M, Giordano S, Di Renzo MF, Comoglio PM. 1997. Control of invasive growth by the HGF receptor family. J Cell Physiol 173:183-186.
21. Matsumoto K, Hashimoto K, Yoshikawa K, Nakamura T. 1991. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res 196:114-120.
22. McCawley LJ, O'Brien P, Hudson LG. 1998. Epidermal Growth Factor (EGF)-and Scatter Factor/Hepatocyte Growth Factor (SF/HGF)-mediated keratinocyte migration is coincident with induction of matrix metalloproteases. J Cell Physiol 176:255-265.
23. Naka T, Iwamoto Y, Shinohara N, Ushijima M, Chuman H, Tsuneyoshi M. 1997. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Mod Pathol 10:832-838.
24. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H. 1999. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85:1894-1902.
25. Nakamura T, Teramoto H, Ichihara A. 1986. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 86:6489-6493.
26. Naldini L, Vigna E, Ferracini R, Longati P, Gandino L, Prat M, Comoglio PM. 1991. The tyrosine kinase encoded by the MET proto-ovogene is activated by autophosphorylation. Mol Cell Biol 11: 1793-1803.
27. Olivero M, Valente G, Bardelli A, Longati P, Ferrero N, Cracco C, Terrone C, Rocca-Rossetti S, Comoglio PM, Di Renzo MF. 1999. Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. Int J Cancer 82(5):640-643.
28. Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, Vande Woude GF. 1986. Mechanism of Met oncogene activation. Cell 45: 895-904.
29. Porte H, Triboulet JP, Kotelevets L, Carrat F, Prevot S, Nordlinger B, DiGioia Y, Wurtz A, Comoglio P, Gespach C, Chastre E. 1998. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. Clin Cancer Res 4:1375-1382.
30. Prat M, Narsimham RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. 1991. The receptor encoded by the human c-Met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49:323-328.
31. Ried S, Jager C, Jeffers M, Vande Woude GF, Graeff H, Schmitt M, Lengyel E. 1999. Activation mechanisms of urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor. J Biol Chem 274:16377-16386.
32. Rock MG, Pritchard DJ, Unni KK. 1984. Metastases from histologically benign giant-cell tumor of bone. J Bone Joint Surg [Am] 66(2):269-274.
33. Rong S, Jeffers M, Resau JH, Tsarfaty I, Oskarsson M, Vande Woude GF. 1993. Met expression and sarcoma tumorigenicity. Cancer Res 53:5355-5360.
34. Rong S, Segal S, Anver M, Resau JH, Vande Woude GF. 1994. Invasiveness and metastasis of NIH 3T3 cells induced by Met-Hepatocyte Growth Factor/Scatter Factor autocrine stimulation. Proc Natl Acad Sci USA 91:4731-4735.
35. Rong S, Donehower LA, Hansen MS, Strong L, Tainsky M, Jeffers M, Resau JH, Hudson E, Tsarfati I, Vande Woude GF. 1995. Met proto-oncogene product is overexpressed in tumors of p53 deficient mice and tumors of Li Fraumeni patients. Cancer Res 55:1963-1970.
36. Santos OFP, Barros EJG, Yang X-M, Matsumoto K, Nakamura T, Park M, Nigam S, 1994. Involvement of hepatocyte growth factor in kidney development. Dev Biol 163:525-529.
37. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Zbar B, et al. 1997. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68-73.
38. Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weirich G, Miller M, Lubensky I, Neumann HP, Brauch H, Decker J, Vocke C, Brown JA, Jenkins R, Richard S, Bergerheim U, Gerrard B, Dean M, Linehan WM, Zbar B. 1999. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18(14):2343-2350.
39. Scotlandi K, Baldini N, Oliviero M, Di Renzo MF, Martano M, Serra M, Manara MC, Comoglio PM, Ferracini R. 1996. Expression of Met/Hepatocyte growth factor receptor gene and malignant behavior of muscoloskeletal tumors. Am J Pathol 149:1209-1219.
40. Seol DW, Chen Q, Smith ML, Zarnegar R. 1999. Regulation of the c-met proto-oncogene promoter by p53. J Biol Chem 274:3565-3572.
41. Sonnemberg E, Meyer D, Weidner KM, Birchmeyer C. 1993. Scatter Factor/Hepatocyte Growth Factor and its receptor, the c-Met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 123:223-235.
42. Strain AJ. 1993. Hepatocyte growth factor: another ubiquitous cytokine. J Endocrinol 137:1-5.
43. Tamagnone L, Comoglio PM. 1997. Control of invasive growth by Hepatocyite Growth Factor (HGF) and related Scatter Factor. Cytokine Growth Factor Rev 8:129-142.
44. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4353.
45. Zhu QS, Qiu JS. 1994. Cytogenetic analyses on giant cell tumor of bone. Chung-ua Ping Li Hsueh Tsa Chih 23(3):162-165.